Immutep Limited (IMMP)
NASDAQ·Healthcare·Biotechnology
$0.47
-9.76%
Mkt Cap $406.25M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $9.40M | $5.50M | -41.49% | -$0.20 | -$0.22 | -9.90% | — | — |
| Q3 2025 Aug 28, 2025 | — | $1.24M | — | -$0.12 | -$0.18 | -44.02% | — | — |
| Q1 2025 Feb 26, 2025 | $433.24K | $1.95M | +349.69% | -$0.08 | -$0.01 | +88.73% | — | — |
| Q3 2024 Aug 30, 2024 | $1.24M | $1.15M | -6.60% | -$0.08 | -$0.01 | +86.12% | — | — |
| Q2 2024 Apr 29, 2024 | $1.20M | $1.44M | +19.64% | -$0.09 | -$0.01 | +86.06% | — | — |
| Q3 2023 Sep 28, 2023 | $1.41M | $1.21M | -14.40% | -$0.09 | -$0.01 | +84.81% | — | — |
| Q1 2023 Feb 24, 2023 | — | $1.15M | — | -$0.08 | -$0.02 | +80.82% | — | — |
| Q3 2022 Jul 28, 2022 | $674.16K | $702.84K | +4.25% | — | -$0.01 | — | — | — |
| Q1 2022 Feb 22, 2022 | $1.58M | $1.51M | -4.19% | -$0.23 | -$0.01 | +94.03% | — | — |
| Q3 2021 Aug 30, 2021 | $1.44M | $1.24M | -13.79% | -$0.38 | -$0.01 | +97.41% | — | — |
| Q1 2021 Feb 23, 2021 | $1.32M | $1.70M | +28.31% | -$0.36 | -$0.38 | -5.56% | — | — |
| Q3 2020 Aug 25, 2020 | $1.77M | $1.25M | -29.67% | — | -$0.01 | — | — | — |
| Q1 2020 Feb 24, 2020 | — | $5.18M | — | -$0.19 | -$0.01 | +94.41% | — | — |
| Q3 2019 Aug 20, 2019 | — | $97.71K | — | — | -$0.02 | — | — | — |
| Q1 2019 Feb 27, 2019 | — | $1.76M | — | — | -$0.02 | — | — | — |
| Q3 2018 Aug 21, 2018 | — | $1.93M | — | — | -$0.02 | — | — | — |
| Q1 2018 Feb 22, 2018 | — | $3.26M | — | — | -$0.01 | — | — | — |
| Q3 2017 Aug 28, 2017 | — | $3.23M | — | — | -$0.07 | — | — | — |
| Q1 2017 Feb 24, 2017 | — | $1.14M | — | -$0.36 | -$0.01 | +96.20% | — | — |
| Q3 2016 Aug 31, 2016 | — | $130.60K | — | — | -$0.51 | — | — | — |